Acute adrenal insufficiency (AAI) in acute coronary syndrome (ACS) patients is rare and may be frequently underestimated as simple ACS, since symptoms of AAI are nonspecific. Physicians should be fully aware of the possibility of occult AAI combined with ACS, if clinical suspicion is high. Herein, we report a rare case of a 67-year-old female patient with concomitant AAI and drug eluting stent fracture-induced ACS. To our knowledge, there have been no case reports of AAI associated with ACS in Korea.
the ultimate prognosis of AAI critically depends on rapid administration of steroids by attending physician regardless of the underlying illness even before the diagnosis is made. [1, 2] AAI occurs in a substantial proportion of patients with chronic adrenal insufficiency mainly triggered by infectious disease, particularly gastrointestinal infections. [3] However, AAI has not yet been previously described in association with acute coronary syndrome (ACS), as a precipitating factor. This case report shows a concomitant AAI and stent fracture induced ACS, in a 67-year-old female patient who had a past medical history of old myocardial infarction, rheumatoid arthritis, diabetes mellitus and hypertension. Since our case initially presented with classic symptoms and signs of ACS, it may have been overlooked. However, the history of steroid medication, sustained hypotension and unexplained abdominal pain led to high suspicion of AAI and ignorance of secondary adrenal insufficiency. After empirical and immediate steroid replacement with emergent percutaneous coronary intervention (PCI), she achieved clinical remission.
Case Report
A 67-year-old female patient visited our emergency department with a 1-hour history of nausea, vomiting, abdominal pain and retrosternal chest pain. On arrival, her mentality was alert but gradually changed to drowsy status. She experienced new onset chest pain in that morning, which occurred at rest and was typically of squeezing type without radiating pain. The patient had complicated past medical history and comorbidities. Ten years prior to presentation, she had been diagnosed with diabetes mellitus and hypertension. At that time, she was treated with oral hypoglycemics and antihypertensive agents, and her blood glucose and pressure were well controlled. In addition, she had an AMI attack 4 years ago, and a zotarolimus-eluting stent was implanted in the postero-lateral branch of the right coronary artery along with anti-platelet agents. Also, she was diagnosed with rheumatoid arthritis 3 years ago and continually administered triamcinolone Reference range: 7.00-19.4 in the morning and 3.00-10.00 in the afternoon. Chest X-ray and magnetic resonance imaging of the brain showed normal finding.
Abdominal computed tomography did not show the right adrenal gland and any abnormal findings (Fig. 1) .
Electrocardiography (ECG) showed ST segment elevation in lead III as well as reciprocal changes in leads I and augmented vector left (aVL) (Fig. 2) . Echocardiography showed severe hypokinesia in mid to apical segment of the inferior wall, with preserved LV function (ejection fraction, 55%) (Fig. 3 ).
Since the above results were compatible with ACS, she was immediately transferred to the catheterization laboratory.
In addition, we also suspected occult AAI associated with ACS. Because, although fluid resuscitation, inotropics and vasopressor, hypotension (initial blood pressure 68/50 mm Hg) sustained in the patient who has received steroid medication.
Thus, we administered intravenous dexamethasone 5 mg im- And to verify the suspected diagnosis of AAI, the rapid ACTH stimulation test was performed after successful PCI. Then, intravenous hydrocortisone sodium succinate (solucortef) 50 mg was replaced every 6 hours.
The standard high dose ACTH (cosynthropin 250 µg/dl) stimulation test results showed in table 1, which suggested adrenal insufficiency. Basal plasma ACTH, rennin and aldosterone were 17.1 pg/ml (normal value, 20-52 pg/ml) 1.53 ng/ml/h (normal value, 1-4 ng/ml/h) and 98.54 pg/ml (normal value, 50-300 pg/ml) that were coupled with simultaneous measurement of basal serum cortisol.
After several hours of steroid injection and successful PCI, hypotension was dramatically reversed. The next morning, her mental status became completely alert, with improvement in nausea, vomiting, and abdominal pain. Her general condition gradually improved and she was discharged from the hospital and followed up with current glucocorticoid replacement therapy.
Discussion
AAI is a rare but severe condition caused by sudden defective production of adrenal steroids. It is an emergency situation and thus rapid awareness and prompt therapy are critical for survival even before the diagnosis is made. [1, 2] The recent study of
Hahner et al. [3] reported that AAI occurs in a substantial pro- illness. [1, 3, 6, 7] In our case, the pre-existing condition of AAI was an overlooked secondary adrenal insufficiency due to long-term steroid medication, which made the differential diagnosis of AAI more difficult. In addition, the main precipitating factor for AAI was ACS induced by stent fracture.
Coronary stent fracture is a relatively uncommon complication of stent implantation. The reported incidence of stent fracture in patients with drug-eluting stents, including a zotarolimus-eluting stent, as shown in this case, is reported to be between 1% and current angina, myocardial infarction, and even sudden death. [10] In our case, stent fracture resulted in ACS, thereby precipitating AAI.
AAI may present with various clinical symptoms and can be life-threatening if not successfully treated. In particular, AAI associated with acute illness is more difficult to establish a clinical diagnosis as shown in this case. Early diagnosis and successful treatment of such cases can increase cure rate. Herein, we reported the rare case of a 67-year-old female patient with AAI accompanied by ACS due to stent fracture. Further studies are needed to elucidate the pathogenesis of concurrent AAI and ACS.
